Australian firm to start trials of bird flu vaccine
- From: "Chim" <ChimS1@xxxxxxx>
- Date: 22 Sep 2005 05:04:33 -0700
CANBERRA, Sept 22 (Reuters) - Australian company CSL Ltd will begin
human trials of a bird flu vaccine next month as the government warned
travellers on Thursday about an outbreak of the deadly virus in parts
of Asia.
CSL is the world's top maker of human plasma products and spokeswoman
Rachel David said the vaccine against the H5N1 strain of avian flu
would be tested on 400 human volunteers. Results were expected by the
end of the year.
Bird flu has killed a confirmed 64 people in Asia since late 2003.
Indonesia is suffering an outbreak of the disease, which has killed at
least four people while 11 are under observation in hospital with bird
flu-like symptoms.
The Australian government gave CSL A$5 million ($3.8 million) in July
to fast-track development of a vaccine.
"What we're testing in the trials is the dose that we need to use for
the vaccine to be effective. The technology is tried and true but what
we need to find out with this completely new strain is whether the
doses we are using are effective," David said.
She said if the tests were successful then the vaccine could be rushed
into production if needed.
"In an emergency, if the dose that we tested was successful and the
strain remains the same, it would take us three months to produce 40
million doses. We would start to get the product out of the factory
within six weeks," she said.
The most advanced bird flu vaccine is one developed by France's
Sanofi-Aventis, which has proved effective at stimulating an immune
system response in healthy adults.
"That used an enormous dose of antigen. In fact, the dose of antigen
was so large that we wouldn't even go down that path because it would
just take too long to make," David said. Antigen is the key vaccine
component that triggers an immune response.
"Essentially we are all sharing information so that whoever comes up
with the preferred process can share the information as quickly as
possible."
U.S.-based Chiron Corp. aims to test its H5N1 vaccine later this year
and Britain's GlaxoSmithKline Plc plans large-scale clinical trials in
2006.
The Australian government reissued a flood of travel warnings for Asia
to alert Australians to the bird flu outbreak.
The H5N1 strain first emerged in Hong Kong in 1997, where it killed six
people, and surfaced again on the Korean peninsula in 2003.
It has since been found in birds in Cambodia, China, Indonesia, Japan,
Kazakhstan, Laos, Malaysia, Mongolia, Philippines, Russia, Taiwan,
Thailand and Vietnam.
($1 ? A$1.30)
09/22/05 10:24 ET
Copyright 2005 Reuters Limited. All rights reserved. Republication or
redistribution of Reuters content, including by framing or similar
means, is expressly prohibited without the prior written consent of
Reuters. Reuters shall not be liable for any errors or delays in
content, or for any actions taken in reliance thereon. All active
hyperlinks have been inserted by AOL.
.
- Prev by Date: Indonesia to ban poultry farms in capital
- Next by Date: Close contact could see humans spread bird flu-WHO
- Previous by thread: Indonesia to ban poultry farms in capital
- Next by thread: Close contact could see humans spread bird flu-WHO
- Index(es):
Relevant Pages
|
